Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$1.85B |
| 2 |
Marvell Technology
MRVL
|
+$1.57B |
| 3 |
Adobe
ADBE
|
+$1.52B |
| 4 |
Celanese
CE
|
+$1.08B |
| 5 |
Cenovus Energy
CVE
|
+$858M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.97B |
| 2 |
Broadcom
AVGO
|
+$1.4B |
| 3 |
D.R. Horton
DHI
|
+$1.26B |
| 4 |
Micron Technology
MU
|
+$1.24B |
| 5 |
GE Aerospace
GE
|
+$1.19B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.09% |
| 2 | Healthcare | 15.85% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 11.99% |
| 5 | Communication Services | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
DT Midstream
DTM
$13.8B
| $78.1M | 0.02% |
1,574,719
-439,324
| -22% | -$21M |
|
302
Extra Space Storage
EXR
$31.3B
| $77.9M | 0.02% |
523,193
+7
| +0% | +$1.05K |
|
303
First Advantage
FA
$3.74B
| $76.9M | 0.02% |
4,988,399
| – | – |
|
304
SentinelOne
S
$7.84B
| $76.3M | 0.02% |
5,056,283
+2,399,658
| +90% | +$40.6M |
|
305
SiriusPoint
SPNT
$2.68B
| $75.4M | 0.02% |
8,350,000
-650,000
| -7% | -$5.94M |
|
306
Silicon Laboratories
SLAB
$7.3B
| $73.2M | 0.02% |
464,000
| – | – |
|
|
FISV
307
Fiserv Inc
FISV
$28.2B
| $67.7M | 0.02% |
536,700
| – | – |
|
308
Unity
U
$19.9B
| $66.6M | 0.02% |
1,532,815
| – | – |
|
309
US Bancorp
USB
$102B
| $66.3M | 0.02% |
2,007,401
+1,082
| +0.1% | +$35K |
|
310
Nutrien
NTR
$32B
| $66.1M | 0.02% |
1,119,111
+510
| +0% | +$32.5K |
|
311
Kenvue
KVUE
$36.7B
| $66.1M | 0.02% |
+2,500,800
| New | +$65.2M |
|
312
On Holding
ONON
$10.3B
| $65.4M | 0.02% |
1,980,610
| – | – |
|
313
Sarepta Therapeutics
SRPT
$1.94B
| $63.8M | 0.02% |
557,383
+291,442
| +110% | +$37.6M |
|
|
CHX
314
DELISTED
ChampionX
CHX
| $62.9M | 0.02% |
2,025,494
+173,732
| +9% | +$4.78M |
|
315
GSK
GSK
$101B
| $62.5M | 0.02% |
1,752,350
+1,032
| +0.1% | +$37K |
|
316
Levi Strauss
LEVI
$8.65B
| $62M | 0.02% |
4,295,300
| – | – |
|
317
Emerson Electric
EMR
$90.5B
| $61.9M | 0.02% |
684,425
+416
| +0.1% | +$35K |
|
318
Guardant Health
GH
$21.6B
| $60.5M | 0.02% |
1,690,281
+690,281
| +69% | +$19.8M |
|
319
Newmont
NEM
$120B
| $59.7M | 0.02% |
1,400,000
+150,000
| +12% | +$6.81M |
|
320
Extreme Networks
EXTR
$3.21B
| $53.8M | 0.01% |
2,065,980
-1,955,795
| -49% | -$38.6M |
|
321
Encompass Health
EHC
$12.2B
| $53.3M | 0.01% |
787,849
| – | – |
|
322
Bentley Systems
BSY
$10.6B
| $53.1M | 0.01% |
979,001
-234,742
| -19% | -$11M |
|
|
BRSL
323
Brightstar Lottery PLC
BRSL
$2.15B
| $52.5M | 0.01% |
1,647,850
-1,082,000
| -40% | -$30.1M |
|
324
CAVA Group
CAVA
$8.31B
| $51.2M | 0.01% |
+1,250,000
| New | +$51.5M |
|
325
Sempra
SRE
$56.4B
| $50.2M | 0.01% |
689,460
+26
| +0% | +$1.95K |
|
Similar funds
Capital Research Global Investors's Q2 2023 Portfolio in Review
As of Q2 2023, Capital Research Global Investors held 446 positions worth $373B, up 6.5% from $350B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Capital Research Global Investors's Q2 2023 filing shows 22 new, 206 increased, 135 reduced and 32 closed positions. Its largest new stake was Capital One: 7,999,882 shares worth $875M. The largest sale was Meta Platforms (Facebook), an estimated $1.97B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q2 2023 buy was Capital One: 7,999,882 shares worth $875M.
- Capital Research Global Investors added most to Texas Instruments in Q2 2023, an estimated $1.85B increase.
- Capital Research Global Investors's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.97B.
- Capital Research Global Investors fully exited Applied Materials in Q2 2023, selling an estimated $911M.
- Capital Research Global Investors's ten largest holdings make up 29% of its $373B portfolio in Q2 2023.
- Capital Research Global Investors opened 22 new positions and closed 32 in Q2 2023.
- Capital Research Global Investors's portfolio value rose 6.5% quarter-over-quarter to $373B.
Based on Capital Research Global Investors's 13F filing for Q2 2023, filed 11 Aug 2023.